

CyGenica - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2017, CyGenica operates in Health Tech offering non-viral, non-toxic delivery solutions for drugs, gene editing components, and antibiotics. The company focuses on overcoming the cellular m...
Funding stage:
Seed
Last funding:
10/06/2021
Total funding:
$1.40 Mn+
Investors
Employee count:
10
Last 90d
10
Last 90d
Web traffic:
1.6K
1.6K
Last 30d
Last 30d
CyGenica: Funding Highlights
Funding highlights of CyGenica and a snapshot of its key metrics.
- Total Funding$1.40 Mn+
- Current StageEarly Stage
- Total Round(s)1
Funding Rounds
FAQs on Funding of CyGenica
Health Tech Funded CyGenica has raised a total funding of $1.40 million as of 11 June 2021 across 1 rounds. Find the details around funding rounds, participating investors, and other insights of CyGenica here...
CyGenica has raised a total of $1.40 million across 1 funding rounds and the last round was raised on 11 June 2021.
CyGenica's key investors include David Rowan, Golden Sparrow Ventures, Sami Mikati and 2 others.
CyGenica's latest funding round was $1.40 million in Early Stage, raised on 11 June 2021.
CyGenica is at the Early stage. Its most recent round was raised on 11 June 2021.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links